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An expanding array of fecal occult blood tests (FOBTs) has
emerged, each with technical advantages and disadvantages.
The traditional chemical method and immunologic
determination of hemoglobin (Hb) are the most commonly
used screening tools for colorectal cancer or premalignant
adenomas in asymptomatic, low-risk populations. Fecal
blood is an ambiguous screening tumor marker for colorectal
cancer, because blood that appears does not arise from the
neoplasm itself but from the circulation. In addition, many
cancers, including the majority of adenomas, do not bleed
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sufficiently or frequently enough to be detected by available
tests. Fecal occult blood should be an important indicator in
the diagnostic evaluation of patients with suspected
gastrointestinal (GI) bleeding of any etiology, not just as an
indication of colorectal cancer.
The traditional chemical FOBTs are based on peroxidase
activity of the hematin portion of Hb. Because these tests
involve the liberation of oxygen from hydrogen dioxide
oxidizing chromogen, false-positive results may be
produced by dietary substances containing sufficient
amounts of hematin. Various chemicals may also interfere
with the analysis and cause false-negative results. To
overcome such disadvantages in chemical tests,
immunologic tests using human Hb antibodies, which
require no dietary restrictions, have high diagnostic accuracy
[1–3]. Because of variable fecal hydration [4], Hb degradation
by proteases [5], absorption by mucin, and the loss of Hb
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antigenicity due to enterobacteria [6,7] and anti-
inflammatory drugs, there is no FOBT that yields both
satisfactory specificity and sensitivity for colorectal neoplasia
[8]. The immunochemical assay of the FOBT is also
inadequate as a screening test for stomach cancer [9].
Detection of fecal transferrin (Tf), which is more stable in
stool than Hb [10], provides an alternative way of diagnosing
the disease in the upper digestive tract. In a study of patients
with colon cancer and polyps, Miyoshi et al demonstrated
that simultaneous determination of Hb and Tf in FOBTs
improves the accuracy of screening [11,12]. The efficacy of
FOBTs for detecting Hb and Tf simultaneously in upper GI
bleeding cases has not been reported in the literature.
The purpose of this study was to evaluate the
performance characteristics of three FOBTs: the chemical
o-toluidine test, the immunochemical OC-Hemodia test,
and the immunochromatographic Quick Chaser Occult
Blood (QCOB) test, which detect human Hb and Tf
simultaneously in cases of upper GI bleeding.
MATERIALS AND METHODS
Samples
We collected 48 consecutive fecal specimens for FOBTs
from 48 adult admission patients with upper GI bleeding in
the Division of Gastroenterology, Department of Internal
Medicine, Kaohsiung Medical University Hospital. Among
those 48 upper GI bleeding cases, 47 cases were confirmed
by GI endoscopy, which was performed by visiting
gastroenterologists from the same hospital. In one case,
endoscopy was not performed because the patient had
open pulmonary tuberculosis. The clinical characteristics
of these upper GI bleeding cases are described in Table 1.
The mean age was 67.1 ± 14.8 years (range, 27–96 years).
The most common causes of upper GI bleeding were gastric
and duodenal ulcers (72.9%). All patients received detailed
explanations of the study methods, including the process of
collecting fecal samples. Fecal specimens with a bloody and
tarry appearance due to active bleeding were excluded, and
all suitable samples were processed immediately after
collection without refrigeration.
Reagent kits
o-Toluidine test kits (Shih-Yung Medical Instruments, Taipei,
Taiwan) were used for conventional chemical methods. The
detection sensitivity of the o-toluidine test is 1:80,000. Latex
agglutination OC-Hemodia reagent kits (Eiken Chemical,
Tokyo, Japan) were used for the immunologic method and
this test was processed automatically by an OC-Sensor
machine. The measurement range of this latex agglutination
method is 50–2,000 ng/mL, and the pathologic cutoff value
was assigned as 100 ng/mL. The QCOB test (Mizuho Medy,
Tosu, Japan) detected Hb and Tf simultaneously by the
immunochromatographic method, and its one-step assay
procedure can be conducted as easily as a commercial urine
pregnancy test. When specimen suspension is dispensed
onto the specimen area, any human Hb and Tf that are
present migrate to the area between the specimen area and
the result area, where they bind with colloidal gold
conjugated to rabbit anti-human Hb and mouse monoclonal
anti-human Tf to form antigen–antibody immunocomplexes.
According to the immunochromatographic principle,
these antigen–antibody immunocomplexes migrate to the
test result area, where they are caught by immobilized
rabbit anti-human Hb and mouse monoclonal anti-human
Tf to form sandwich complexes, made apparent by an easily
readable purple–red color signal, which indicates the
presence of human Hb and human Tf in the specimen. The
measurement range of human Hb or Tf is 50–800 ng/mL.
The detection sensitivities of both human Hb and Tf were
300 ng/mL. The detection sensitivities of these three tests
were confirmed with the standard materials provided by
their manufacturers.
Statistical methods
Statistical significance was evaluated using the r2 test.
A p value of less than 0.05 was defined as statistically
significant.
RESULTS
The frequencies of the positive rates of three FOBTs in
48 upper GI bleeding specimens are shown in Table 2.
Table 1. Clinical characteristics of 48 upper gastrointestinal
bleeding cases
Characteristic No. of cases %
Male 27 56.3
Female 21 43.7
Etiology
Gastric and duodenal ulceration 35 72.9
Esophageal varices 6 12.5
Polyp 4 8.33
Gastric cancer 3 6.25
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The QCOB test was positive in 68.8% (33/48), the highest
among the three tests. The o-toluidine test was positive in
39.6% (19/48), and the OC-Hemodia test was positive in
45.8% (22/48). The QCOB test detected occult blood at
significantly higher positive rates than did the OC-
Hemodia test (p < 0.025). Of the 48 fecal specimens of
upper GI bleeding tested by the QCOB test, 17 (35.4%)
were positive for both substances, six (12.5%) were positive
for Hb only, 10 (20.8%) were positive for Tf only, and 15
(31.3%) were negative for both substances.
The frequencies of positive rates for the various FOBTs
in upper GI bleeding are shown in Table 3. The occult blood
positive rate for the QCOB test was 68.6% (24/35), and
34.3% (12/35) for the o-toluidine test in the gastric and
duodenal ulcer groups of patients with upper GI bleeding.
There was a significant difference of positive rates between
the QCOB test and the o-toluidine test (p < 0.01). All three
gastric cancer cases tested positive in these three occult
blood tests.
Fifteen fecal specimens tested negative in all three types
of occult blood tests.  No fecal specimen was positive with
the o-toluidine test or the OC-Hemodia test that was negative
with the QCOB test.
DISCUSSION
The accuracy of screening tests for cancer can be evaluated,
by a retrospective approach, to study both affected cancer
cases and healthy subjects, although the provision of
follow-up for all subjects who undergo an examination for
false-positive cases presents certain operational limitations.
Nevertheless, the immunochemical FOBT is widely used as
a screening method for colorectal cancer [13,14], and several
studies have suggested that immunochemical FOBTs are
more efficient [15–17]. In our study, we used the OC-
Hemodia test for immunochemical occult blood testing.
Among the three FOBTs used in this study, the OC-
Hemodia test had the lowest pathologic cutoff value for
fecal Hb (100 ng/mL assigned by the manufacturer). The
cutoff value for fecal Hb with the QCOB test was 300 ng/
mL. These values differed from those in a previous study by
Nakama et al, as a result of different immunochemical and
immunochromatographic methods [18].
When we evaluated the possibility of using these kits for
detecting upper GI bleeding, if we only compared the
results for Hb or Tf from the QCOB test, there was no
significant difference in fecal occult blood positive rates
with the OC-Hemodia test. Furthermore, when comparing
combined results for Hb and Tf, the QCOB test revealed
significantly higher positive rates of occult blood (68.8%)
than did the OC-Hemodia test (45.8%) (p < 0.025). There
have been several studies examining the diagnostic accuracy
of FOBTs in the detection of stomach cancer and upper
digestive tract disease [9,19,20]. The results were similar to
our observations that chemical or immunochemical methods
of detecting solely Hb have low rates of success. In the
hospital-based case-control study of Nakama et al, the
immunochemical test was positive in six (14.3%) subjects
with stomach cancer, in 32 (76.2%) subjects with colorectal
cancer, and in 10 (7.9%) healthy subjects, respectively,
showing a significant difference in detection rates between
Table 2. Frequency of positive rates (%) of various fecal occult
blood tests in upper gastrointestinal bleeding
o-Toluidine OC-Hemodia QCOB
19/48* (39.6) 22/48† (45.8) 33/48‡ (68.8)
QCOB = Quick Chaser Occult Blood.
*p < 0.01 by r2 test, compared with the Quick Chaser Occult Blood test.
†p < 0.025 by r2 test, compared with the Quick Chaser Occult Blood test.
‡The positive rates for hemoglobin and transferrin are 56.2% and
47.9%, respectively.
Table 3. Frequency of positive rates (%) of three occult blood tests in upper gastrointestinal bleeding specimens
Diagnosis o-Toluidine OC-Hemodia QCOB
Gastric and duodenal ulcer (n = 35) 12/35 (34.3%) 15/35 (42.9%) 24/35* (68.6%)
Esophageal varices (n = 6) 1/6 (16.7%) 2/6 (33.3%) 3/6 (50%)
Polyps (n = 4) 1/4 (25%) 1/4 (25%) 2/4 (50%)
Gastric cancer (n = 3) 3/3 (100%) 3/3 (100%) 3/3 (100%)
QCOB = Quick Chaser Occult Blood.
*Compared with the o-toluidine test, r2 = 6.92, p < 0.01.
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subjects with stomach cancer and colorectal cancer (p < 0.01)
[9]. Thus, the immunochemical FOBT was determined as an
inadequate screening test for stomach cancer. The authors
suggested that examination of the upper digestive tract is
unnecessary in cases where the results of FOBTs are positive
with no sign of colorectal disease. The false-negative results
of immunochemical tests occur because Hb derived from
the upper digestive tract is broken down in the intestinal
tract. Therefore, the antigenicity of Hb is lost and cannot be
detected by the immunochemical occult blood test [13,21].
In this study, 15 cases were negative in all three FOBTs. In
addition to the lost antigenicity in the intestinal tract as
mentioned above, the false-negative result of FOBTs was
probably due to our exclusion of stool specimens with an
obvious bloody and tarry appearance.
In this study, 10 cases (20.8%) of upper GI bleeding were
occult blood positive for Tf only. Schade et al [22] and Ward
et al [23] observed that Tf is a glycoprotein that is highly
resistant to bacterial degradation as well as to breakdown
by digestive enzymes, and Tf was found to be the most
stable, suggesting that it could perhaps be used as a marker
of GI bleeding. In Miyoshi’s studies, 18% of fecal specimens
were positive for Tf alone, suggesting that Tf is stable in
feces [11].
Our results revealed that QCOB tests have significantly
higher positive rates than that of the QC-Hemodia method
in upper GI bleeding cases. These false-negative findings
via the immunochemical method were also seen in studies
by Burton et al [24] and Tada et al [25]. Their observations
demonstrated that bleeding from the GI tract is rarely
detectable by immunologic tests as a result of the effects of
intestinal bacteria and digestive juices.
In the studies by Rockey et al, the possibility is raised
that a combination of a highly sensitive guaiac-based FOBT
plus an immunochemical test could help to differentiate
occult upper from lower GI bleeding [26]. They found that
a positive SENSA test (guaiac test), as well as a positive
immunochemical test, would raise the likelihood that
bleeding is from the lower GI tract. In contrast, a positive
SENSA test in the setting of a negative immunochemical
test could be indicative of upper GI bleeding. Harewood et
al compared three FOBTs in upper GI bleeding by ingested
autologous blood and observed that the HQT (heme-
porphyrin) test detected occult upper GI blood loss
significantly more frequently than the HO (guaiac) test and
HS (immunochemical) test [27].
The QCOB test by the immunochromatographic method
is ready to use, without prior preparation of reagents and is
machine independent. The one-step assay procedure can be
handled easily by medical technologists, even for house-
call patients. Therefore, this test can be a better choice for
FOBTs in the countryside. However, the QCOB test is not
cost effective compared with other methods.
Based on our observations from this study, the QCOB
test revealed significantly higher positive rates of occult
blood (68.8%) than did the OC-Hemodia test (45.8%) and
the o-toluidine test (39.6%). Thus, the QCOB test
(combination assay of human Hb and Tf) is superior to the
other two tests for the detection of fecal occult blood in
patients with upper GI bleeding.
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